PFM
Privium Fund Management Portfolio holdings
AUM
$543M
1-Year Est. Return
99.51%
This Fund
S&P 500
1 Year Est. Return
+99.51%
AUM
$543M
AUM Growth
-$13.1M
(-2.4%)
Holding
65
Top Buys
| 1 | +$7.74M | |
| 2 | +$6.94M | |
| 3 | +$4.76M | |
| 4 |
Biogen
BIIB
|
+$3.52M |
| 5 |
enGene Holdings
ENGN
|
+$2.82M |
Top Sells
| 1 | +$16.9M | |
| 2 | +$6.87M | |
| 3 | +$6.41M | |
| 4 |
Arrowhead Research
ARWR
|
+$3.71M |
| 5 |
Sea Limited
SE
|
+$3.26M |
Sector Composition
| 1 | Healthcare | 29.46% |
| 2 | Consumer Discretionary | 27.3% |
| 3 | Technology | 25.78% |
| 4 | Financials | 8.49% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tesla
TSLA
$1.51T
| $103M | 18.92% |
228,500
-15,500
|
|
||
2
Shopify
SHOP
$157B
| $66M | 12.15% |
410,000
-5,000
|
|
||
3
Spotify
SPOT
$106B
| $39.5M | 7.27% |
68,000
-27,000
|
|
||
4
Palantir
PLTR
$328B
| $35.5M | 6.55% |
200,000
|
|
||
5
Amazon
AMZN
$2.25T
| $27.9M | 5.14% |
121,000
-28,000
|
|
||
|
6
Arrowhead Research
ARWR
$8.86B
| $26.4M | 4.87% |
398,204
-75,747
|
|
||
7
Ionis Pharmaceuticals
IONS
$13.1B
| $19.1M | 3.51% |
240,824
-8,070
|
|
||
8
Coinbase
COIN
$46.4B
| $17.9M | 3.29% |
79,000
|
|
||
9
Lemonade
LMND
$3.87B
| $17.7M | 3.25% |
248,259
+103,259
|
|
||
|
10
Sea Limited
SE
$64.2B
| $17.6M | 3.24% |
138,000
-22,000
|
|
||
11
NVIDIA
NVDA
$4.31T
| $15.1M | 2.78% |
81,000
|
|
||
|
12
Biogen
BIIB
$28.2B
| $12.9M | 2.38% |
73,480
+21,555
|
|
||
13
Advanced Micro Devices
AMD
$326B
| $12.8M | 2.37% |
60,000
|
|
||
14
ProQR Therapeutics
PRQR
$167M
| $10.8M | 1.99% |
5,357,762
+359,475
|
|
||
15
Iris Energy
IREN
$13.6B
| $10.6M | 1.95% |
280,000
+150,000
|
|
||
16
AST SpaceMobile
ASTS
$22.5B
| $10.5M | 1.94% |
145,000
+35,000
|
|
||
17
Axsome Therapeutics
AXSM
$8.38B
| $10.4M | 1.91% |
56,878
+4,146
|
|
||
18
uniQure
QURE
$974M
| $9.96M | 1.83% |
416,270
+30,270
|
|
||
19
Arcutis Biotherapeutics
ARQT
$3.3B
| $8.89M | 1.64% |
305,972
|
|
||
20
Ultragenyx Pharmaceutical
RARE
$2.26B
| $8.22M | 1.51% |
357,502
+67,698
|
|
||
21
Viridian Therapeutics
VRDN
$2.8B
| $5.4M | 0.99% |
+173,516
|
|
||
22
UroGen Pharma
URGN
$1.02B
| $5.03M | 0.93% |
214,622
+18,000
|
|
||
23
Vertex Pharmaceuticals
VRTX
$126B
| $4.24M | 0.78% |
9,355
+1,055
|
|
||
24
Merck
MRK
$307B
| $3.85M | 0.71% |
36,593
-27,800
|
|
||
25
Wave Life Sciences
WVE
$2.59B
| $3.28M | 0.6% |
193,010
+23,010
|
|